[go: up one dir, main page]

DE60028613D1 - Schlaffördernde wirkung von nicht-pathogenen milchsäurebakterien - Google Patents

Schlaffördernde wirkung von nicht-pathogenen milchsäurebakterien

Info

Publication number
DE60028613D1
DE60028613D1 DE60028613T DE60028613T DE60028613D1 DE 60028613 D1 DE60028613 D1 DE 60028613D1 DE 60028613 T DE60028613 T DE 60028613T DE 60028613 T DE60028613 T DE 60028613T DE 60028613 D1 DE60028613 D1 DE 60028613D1
Authority
DE
Germany
Prior art keywords
cncm
pathogenic
drug
acid bacteria
sleep
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60028613T
Other languages
English (en)
Other versions
DE60028613T2 (de
Inventor
M Krueger
J Pabst
Chantal Cayuela
Marie-Christine Degivry
Donna Hartley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gervais Danone SA
Original Assignee
Gervais Danone SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gervais Danone SA filed Critical Gervais Danone SA
Application granted granted Critical
Publication of DE60028613D1 publication Critical patent/DE60028613D1/de
Publication of DE60028613T2 publication Critical patent/DE60028613T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C11/00Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/10Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
    • A23C11/103Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
    • A23C11/106Addition of, or treatment with, microorganisms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1238Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using specific L. bulgaricus or S. thermophilus microorganisms; using entrapped or encapsulated yoghurt bacteria; Physical or chemical treatment of L. bulgaricus or S. thermophilus cultures; Fermentation only with L. bulgaricus or only with S. thermophilus
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L11/00Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/60Drinks from legumes, e.g. lupine drinks
    • A23L11/65Soy drinks
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065Microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46Streptococcus ; Enterococcus; Lactococcus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/853Lactobacillus
    • Y10S435/854Lactobacillus acidophilus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/885Streptococcus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60028613T 1999-12-20 2000-12-20 Schlaffördernde wirkung von nicht-pathogenen milchsäurebakterien Expired - Lifetime DE60028613T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US466768 1983-02-15
US09/466,768 US6444203B2 (en) 1999-12-20 1999-12-20 Administering bacteria to improve sleep
PCT/EP2000/013020 WO2001045722A1 (en) 1999-12-20 2000-12-20 Somnogenic activity of non-pathogenic lactic acid bacteria

Publications (2)

Publication Number Publication Date
DE60028613D1 true DE60028613D1 (de) 2006-07-20
DE60028613T2 DE60028613T2 (de) 2007-05-31

Family

ID=23853027

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60028613T Expired - Lifetime DE60028613T2 (de) 1999-12-20 2000-12-20 Schlaffördernde wirkung von nicht-pathogenen milchsäurebakterien

Country Status (19)

Country Link
US (1) US6444203B2 (de)
EP (1) EP1251860B1 (de)
JP (1) JP4527922B2 (de)
AT (1) ATE328601T1 (de)
AU (1) AU3161801A (de)
BR (1) BR0016523A (de)
CA (1) CA2394802A1 (de)
CZ (1) CZ20022483A3 (de)
DE (1) DE60028613T2 (de)
DK (1) DK1251860T3 (de)
ES (1) ES2266023T3 (de)
HU (1) HUP0300025A3 (de)
MX (1) MXPA02006116A (de)
PL (1) PL202465B1 (de)
PT (1) PT1251860E (de)
RU (1) RU2262943C2 (de)
SK (1) SK10662002A3 (de)
WO (1) WO2001045722A1 (de)
ZA (1) ZA200204974B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2785809B1 (fr) * 1998-11-18 2001-01-12 Gervais Danone Sa Selection et utilisations de souches de bacteries lactiques modulatrices de l'immunite non-specifique
TW200533299A (en) * 2004-03-31 2005-10-16 Calpis Co Ltd Functional food for improving endogenous rhythm of melatonin secretion, and functional food for improving circadian rhythm
US20150147298A1 (en) * 2006-07-24 2015-05-28 CortControl, Inc. Sleep enhancement with cortisol reduction medical food
EP2110028A1 (de) * 2008-04-15 2009-10-21 Nestec S.A. Bifidobacterium longum und hippocampale BDNF-Expression
US9034314B2 (en) * 2008-11-03 2015-05-19 Nestec S.A. Nutritional composition comprising probiotics and improving sleep patterns
AU2014221272B2 (en) * 2008-11-03 2016-01-21 Société des Produits Nestlé S.A. A nutritional composition comprising probiotics and improving sleep patterns
FR2938552B1 (fr) 2008-11-19 2010-12-03 Gervais Danone Sa Souche hypocholesterolemiante de lactobacillus delbrueckii
JP5923238B2 (ja) * 2010-07-07 2016-05-24 アサヒグループホールディングス株式会社 迷走神経活性化剤
CN104769100A (zh) * 2012-10-25 2015-07-08 热尔韦·达诺尼公司 用于治疗幽门螺杆菌感染的嗜热链球菌菌株
CN106132424A (zh) * 2014-03-25 2016-11-16 株式会社益力多本社 睡眠质量改善剂
JP6127169B2 (ja) * 2016-02-15 2017-05-10 三基商事株式会社 睡眠改善剤
JP7154473B2 (ja) * 2017-05-31 2022-10-18 学校法人順天堂 疲労回復用および/または疲労蓄積予防用組成物
US20200323227A1 (en) * 2017-12-19 2020-10-15 Compagnie Gervais Danone Fermented dairy compositions and methods of preparing the same
CN111297915B (zh) * 2019-04-12 2021-11-23 首都医科大学附属北京友谊医院 治疗帕金森病快速眼动期睡眠行为障碍的益生菌组合物、制剂及用途
CN114727616A (zh) * 2019-08-09 2022-07-08 达能日尔维公司 发酵的组合物及其制备方法
EP4009798A1 (de) * 2019-08-09 2022-06-15 Compagnie Gervais Danone Fermentierte pflanzenbasierte probiotische zusammensetzungen und verfahren zu ihrer herstellung
JP2021123562A (ja) * 2020-02-05 2021-08-30 雪印メグミルク株式会社 睡眠促進用組成物及び組成物を含む食品、医薬品、飼料
JP6873291B1 (ja) 2020-02-05 2021-05-19 雪印メグミルク株式会社 睡眠促進用組成物及び組成物を含む食品、医薬品、飼料
JP7593740B2 (ja) * 2020-03-02 2024-12-03 株式会社明治 睡眠の質改善用組成物、全体的健康感改善用組成物および活力向上用組成物
CN113854457A (zh) * 2021-09-18 2021-12-31 山东绿丰生态农业股份有限公司 一种助睡眠促消化樱桃酵素固体饮品及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110476A (en) * 1977-01-10 1978-08-29 Johnson/Rhodes Cultured Foods, Inc. Preparation of liquid and frozen yogurt products
CH654330A5 (en) 1980-01-31 1986-02-14 Sp Kt Bjuro Dezi Process for the preparation of a biological product for stimulating vitality of humans and animals
US4624853A (en) * 1983-02-07 1986-11-25 S. C. Johnson & Son, Inc. Instant yogurt food product
US4698330A (en) 1983-06-27 1987-10-06 President & Fellows Of Harvard College Somnogenic compositions and method of use
DE3624010A1 (de) 1986-07-16 1988-01-28 Sen Wilhelm Kanne Arznei- bzw. heilmittel zur behandlung des ganzheitlichen menschlichen organismus
US4837036A (en) * 1987-05-22 1989-06-06 The Pro-Mark Companies, Inc. Low fat thin-bodied yogurt product and method
RU2012347C1 (ru) * 1990-06-08 1994-05-15 Колосовский Эрнест Дмитриевич Средство для лечения бессоницы
US5716615A (en) 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
CN1114217A (zh) 1994-06-23 1996-01-03 南京肉类联合加工厂 生物活性口服液
DK0689769T3 (da) * 1994-06-29 2000-02-07 Nestle Sa Fremgangsmåde til fremstilling af et gæret foder til dyr, samt det produkt, der opnås ved fremgangsmåden
AUPM864894A0 (en) 1994-10-07 1994-11-03 Borody, Thomas Julius Treatment of bowel-dependent neurological disorders
DK0794707T3 (da) * 1995-01-02 1999-07-26 Gervais Danone Co Mælkesyreferment og anvendelse deraf til fremstilling af antidiarréiske produkter
FR2771600B1 (fr) * 1997-11-28 2000-06-09 Gervais Danone Co Preparation de produits alimentaires par fermentation d'un melange de jus de soja et d'hydrolysat cerealier par streptococcus thermophilus
FR2793257B1 (fr) * 1999-05-06 2001-07-27 Gervais Danone Sa Bacteries lactiques a proprietes anxiolytiques, et leurs utilisations

Also Published As

Publication number Publication date
BR0016523A (pt) 2002-09-24
HUP0300025A2 (en) 2003-05-28
EP1251860A1 (de) 2002-10-30
DE60028613T2 (de) 2007-05-31
ES2266023T3 (es) 2007-03-01
JP4527922B2 (ja) 2010-08-18
CZ20022483A3 (cs) 2004-08-18
CA2394802A1 (en) 2001-06-28
HUP0300025A3 (en) 2004-12-28
WO2001045722A9 (en) 2002-09-12
RU2002119413A (ru) 2004-02-27
JP2003517828A (ja) 2003-06-03
US6444203B2 (en) 2002-09-03
RU2262943C2 (ru) 2005-10-27
ZA200204974B (en) 2005-10-31
ATE328601T1 (de) 2006-06-15
SK10662002A3 (sk) 2005-06-02
MXPA02006116A (es) 2004-08-23
PL202465B1 (pl) 2009-06-30
DK1251860T3 (da) 2006-10-16
US20010051152A1 (en) 2001-12-13
WO2001045722A1 (en) 2001-06-28
PL356459A1 (en) 2004-06-28
EP1251860B1 (de) 2006-06-07
PT1251860E (pt) 2006-10-31
AU3161801A (en) 2001-07-03

Similar Documents

Publication Publication Date Title
DE60028613D1 (de) Schlaffördernde wirkung von nicht-pathogenen milchsäurebakterien
EA200101262A1 (ru) Диетическая или фармацевтическая композиция для применения в целях профилактики или лечения гипероксалурии
Blum et al. Adhesion studies for probiotics: need for validation and refinement
GB2338245A (en) Immunity enhancing lactic acid bacteria
GB0124580D0 (en) New composition
NO165553C (no) Fremgangsmaate for fremstilling naturlig karbonert drikke.
DK1539927T3 (da) Probiotisk bakterie: Lactobacillus fermentum
PT2201955T (pt) Bifidobacterium lactis bb-12 na prevenção primária de doenças atópicas
DK1005353T3 (da) Farmaceutisk præparat omfattende Lactobacillus casei rhamnosus
BR9403191A (pt) Lactobacillus bulgaricus tendo produção de ácido diminuída, e, composição de alimento
SE9501719D0 (sv) Pharmaceutical composition
DK0858501T3 (da) Mælkesyrebakteriepræparater samt deres anvendelse til fremstilling af kolesterolsænkende produkter
DE60012521D1 (de) BAKTERIENSTAMM LACTOBACILLUS ACIDOPHILUS N.V. EP 317/402 NARINE, WELCHER ZUR HERSTELLUNG VON ZUSAMMENSETZUNGEN UND VON DIäTETISCHEN, THERAPEUTISCHEN UND PROPHYLAKTISCHEN PRODUKTEN ZUR BEHANDLUNG VON DYSBAKTERIOSE UND DEREN FOLGEN VERWENDET WIRD
EE05412B1 (et) Bifidobacterium'i perekonna probiootiliste tvede skriinimise meetod
AU5069500A (en) Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
RU92001155A (ru) Способ получения ферментированного продукта из пахты
De Petrino et al. Influence of the oral administration of different lactic acid bacteria on intestinal microflora and iga‐secreting cells in mice treated with ampicillin
MD1853G2 (ro) Preparat microbian eubiotic pentru profilaxia şi tratamentul disbacteriozei intestinale
GEP20033132B (en) Bacteriological Preparations
FI923829A0 (fi) Uusi Lactobacillus acidophilus-kanta ja sen käyttö elintarvikkeiden, erityisesti meijerituotteiden valmistamiseen
ES2155783B1 (es) Nueva utilizacion de lactobacillus casei para la preparacion de leches fermentadas para el tratamiento de niveles inmunitarios deprimidos.
KR960034401A (ko) 프로바이오틱에 적합한 비피더스균 및 그의 분말 비피더스균 제제
DK1016709T3 (da) Lactobacillus helveticus-bakterie med höj evne til at producere tripeptider, syrnet mælkeprodukt og fremgangsmåde til fremstilling heraf
BG104489A (en) Probiotic foodstuff, its application as immunomodulating means and a ferment for its preparation
MX9602290A (es) Producto de leche fermentada por el cultivo en simbiosis de cepas de lactobacillus casei crl atcc 55544 y lactobacillus acidophilus crl 730 atcc 55543.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: COMPAGNIE GERVAIS DANONE, PARIS, FR